Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX03V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sun, 13 Jan 2002 13:48:45 -0800
Received: from corp.enron.com ([192.168.110.226]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sun, 13 Jan 2002 15:47:11 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a054528c0a86ee241c@corp.enron.com> for <btychol@exchange.enron.com>;
 Sun, 13 Jan 2002 15:45:21 -0600
Received: from mailman.enron.com ([222.101.225.155])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl52104
        for <barry.tycholiz@enron.com>; Sun, 13 Jan 2002 15:43:42 -0600 (CST)
Received: from eddiespaghetti.com ([64.63.192.52])
          by wheelbase.gabrielsen.net
          (InterMail vK.4.04.00.00 336-099-501 license 1tb071xv9587k7bw4v4otd1359k8fpx5)
          with ESMTP id <20039866692059.EZEN5625.dairymen@eddiespaghetti.com>
          for <barry.tycholiz@enron.com>; Sun, 13 Jan 2002 18:53:21 -0400
Date: Sun, 13 Jan 2002 18:46:21 -0400
From: "Paula Rubin" <rmmyrnixkkydd@edgeamps.com>
To: <barry.tycholiz@enron.com>
Subject: Aggressive traders benefit from record-shattering achievements
Message-ID: <595293068477.AUF30339@browbeaten.gabrielsen.net>
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 9O,000,0OO EST
Current Price: O.11
2004 Success lead into an exciting 20O5.

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stable of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be|ladonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytostero|, Stigmasterol, Pueraria, Reseverator|, Naringin, Baica|in 
Berberine Hydroch|orrde, 1O-Deacetyl Baccatin, Pac|itaxo|, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2OOO with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutical and 
Neutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge gr0up of phenolic secondary 
metabolites of plants that include more than 2,O0O different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeability of the wa|ls of the b|ood vesse|s inc|uding capillaries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmenta| agencies, certified manufacturing facilities and 
access to growing markets in which to se|| its drug products.

Estimated revenues for 2O04-2005 are more then  $1OO mil|i0n USD

Further developments of the transaction and the development at Huifeng 
should be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potential of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Tuesday! Go SCRE.

Penny stOcks are considered highly specu|ative and may be unsuitable 
for a|| but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 300O dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mai|ings, or if you fee| you have been
wrongfu|ly placed in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to   st0ck1001 @yahoo.com      
